Novartis AG (ADR) (NYSE:NVS)

CAPS Rating: 5 out of 5

Operates in the business of patent-protected and generic pharmaceuticals as well as consumer health products.


Player Avatar TMFTailwind (85.30) Submitted: 5/30/2013 11:58:12 AM : Outperform Start Price: $71.41 NVS Score: +9.09

NVS has an enviable strategic position with a nice pipeline of late-stage products. Diversified product lines buffer the company from difficulties in any one segment. NVS also benefits from increased adoption of generic drugs. Steady, defensive big pharma play with a good margin of safety at current levels.

Featured Broker Partners